NONOF - Most patients discontinue Novo's Wegovy Ozempic within two years: report
2024-07-10 08:19:40 ET
More on Novo Nordisk
- Novo Nordisk: Buy On Dips
- Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy
- Novo Nordisk: Leading The Fight Against Diabetes And Obesity
- Study finds patients lost more weight on Mounjaro than Ozempic
- Small, mid-size biotechs could see M&A action in H2 - PwC